Xynomic Pharma Plans 4 Clinical Trials of Abexinostat for Lymphoma
News
Xynomic Pharma announced it has completed a new Series B financing round and now will initiate eight clinical trials, four of which are for different types of lymphoma, in the next 12 ... Read more